iCARE DOA 2 Panels (Configurable) Rapid Screen Test

iCARE DOA 2 Panels (Configurable) Rapid Screen Test Kit

iCARE DOA 2 Panels (Configurable) Rapid Screen Test: A Reliable Solution for Drug Testing

iCARE DOA 2 Panels Rapid Screen Test Key Features:

  • Rapid Screening: Conducts a qualitative, competitive binding immunoassay for configured drugs and metabolites in urine at or above the cutoff level of 50ng/mL.
  • Global Conformance: Meets USA, European, and International drug of abuse test standards for comprehensive reliability.
  • Design Flexibility: Offers a variety of design specifications to cater to diverse testing requirements.
  • High Specificity: Ensures accurate and specific results, minimizing false positives or negatives.
  • User-Friendly: Simple to use with results available in just 5 minutes, making it ideal for quick and efficient testing.
  • Storage Convenience: Can be stored at room temperature, facilitating easy storage and access.
  • Portable: Lightweight and easy to carry, suitable for Point-of-Care Testing (POCT) in various settings.

iCARE DOA 2 Panels (Configurable) Rapid Screen Test is a cutting-edge Drug of Abuse (DOA) Rapid Screen Test Kit offered by Jal Medical. This product is designed for rapid and qualitative detection of configured drugs and their metabolites in urine. The competitive binding immunoassay ensures accuracy, with results available in just 5 minutes. It is crucial to note that the test is not intended to monitor drug levels but to screen urine for the presence of configured drugs and their metabolites.

This innovative screening kit conforms to USA, European, and International drug of abuse test standards, ensuring reliability and accuracy. With a range of design specifications available, users can choose the configuration that best suits their needs. The test specifically targets a variety of chemicals, including AMP, BAR, BZO, BUP, COC, MDMA, KAN, THC, MTD, OPI, OCD, PCP, and TCA, making it a comprehensive solution for drug screening.

Technical Specifications of DOA 2 Panels Rapid Screen Test:

  • Model Name: Refer to catalogue
  • Packing: Available in 50T or 100T per box for convenience and flexibility.
  • Specimen: Uses urine as the testing sample.
  • Format: Panel configuration for easy handling.
  • Type of Test: Allows a combination of any 2 of the listed drugs for flexible testing options.
  • Specificity: Achieves 100% specificity, reducing the likelihood of false results.
  • Sensitivity: Boasts a 90% sensitivity rate, ensuring reliable detection of configured drugs.
  • Minimum Order Quantity (MOQ): 2,000 units for efficient supply chain management.
  • Shelf Life: Long shelf life of 24 months from the date of production, providing reliability over time.
  • Private Labeling: Offers the option of private labeling for branding purposes with a minimum order quantity of 5,000 units.
  • Certification: Holds CE, FDA, and 510K certifications for most similar products, attesting to its quality and compliance.

Jal Medical, a leading name in the industry, extends its reach to 57 African countries, including Nigeria, Egypt, South Africa, and others, providing quality healthcare solutions. The company also serves the Caribbean and Central Asian countries, reaffirming its commitment to global health and well-being. Choose iCARE DOA 2 Panels (Configurable) Rapid Screen Test for accurate, rapid, and reliable drug screening in diverse settings.